Literature DB >> 32150462

Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis.

Pankaj Gupta1, Varun Bansal1, Praveen Kumar-M2, Saroj K Sinha3, Jayanta Samanta3, Harshal Mandavdhare3, Vishal Sharma3, Usha Dutta3, Rakesh Kochhar3.   

Abstract

OBJECTIVE: To evaluate the sensitivity, specificity, and diagnostic odds ratio (DOR) of Doppler ultrasound, CT, and MRI in the diagnosis of Budd Chiari syndrome (BCS).
METHODS: We performed a literature search in PubMed, Embase, and Scopus to identify articles reporting the diagnostic accuracy of Doppler ultrasound, CT, and MRI (either alone or in combination) for BCS using catheter venography or surgery as the reference standard. The quality of the included articles was assessed by using the Quality Assessment of Diagnostic Accuracy Studies-2 tool.
RESULTS: 11 studies were found eligible for inclusion. Pooled sensitivities and specificities of Doppler ultrasound were 89% [95% confidence interval (CI), 81-94%, I2 = 24.7%] and 68% (95% CI, 3-99%, I2 = 95.2%), respectively. Regarding CT, the pooled sensitivities and specificities were 89% (95% CI, 77-95%, I2 = 78.6%) and 72% (95% CI, 21-96%, I2 = 91.4%), respectively. The pooled sensitivities and specificities of MRI were 93% (95% CI, 89-96%, I2 = 10.6%) and 55% (95% CI, 5-96%, I2 = 87.6%), respectively. The pooled DOR for Doppler ultrasound, CT, and MRI were 10.19 (95% CI: 1.5, 69.2), 14.57 (95% CI: 1.13, 187.37), and 20.42 (95% CI: 1.78, 234.65), respectively. The higher DOR of MRI than that of Doppler ultrasound and CT shows the better discriminatory power. The area under the curve for MRI was 90.8% compared with 88.4% for CT and 86.6% for Doppler ultrasound.
CONCLUSION: Doppler ultrasound, CT and MRI had high overall diagnostic accuracy for diagnosis of BCS, but substantial heterogeneity was found. Prospective studies are needed to investigate diagnostic performance of these imaging modalities. ADVANCES IN KNOWLEDGE: MRI and CT have the highest meta-analytic sensitivity and specificity, respectively for the diagnosis of BCS. Also, MRI has the highest area under curve for the diagnosis of BCS.

Entities:  

Mesh:

Year:  2020        PMID: 32150462      PMCID: PMC7217562          DOI: 10.1259/bjr.20190847

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  30 in total

1.  [Study on between magnetic resonance venography and digital subtraction angiography on the inferior vena cava obstructive interface morphology of Budd-Chiari syndrome].

Authors:  Xin Lu; Kai Xu; Qing-qiao Zhang; Chun Yang; Shao-dong Li; Jiang-shan Li; Yu-tao Rong; Mao-heng Zhu
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2011-12

Review 2.  Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews.

Authors:  Johannes B Reitsma; Afina S Glas; Anne W S Rutjes; Rob J P M Scholten; Patrick M Bossuyt; Aeilko H Zwinderman
Journal:  J Clin Epidemiol       Date:  2005-10       Impact factor: 6.437

3.  Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome.

Authors:  S Gupta; S Barter; G W Phillips; R N Gibson; H J Hodgson
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

4.  Budd-Chiari syndrome: a prospective analysis of hepatic vein obstruction on ultrasonography, multidetector-row computed tomography and MR imaging.

Authors:  Sid Ahmed Faraoun; Mohamed El Amine Boudjella; Nabil Debzi; Nawel Afredj; Youcef Guerrache; Naima Benidir; Chafik Bouzid; Kamel Bentabak; Philippe Soyer; Salah Eddine Bendib
Journal:  Abdom Imaging       Date:  2015-08

5.  Diagnostic accuracy of magnetic resonance angiography for Budd-Chiari syndrome: A meta-analysis.

Authors:  Peng Xu; Lulu Lyu; Muhammad Umair Sami; Xin Lu; Haitao Ge; Yutao Rong; Chunfeng Hu; Kai Xu
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

6.  Clinical significance of multislice spiral CT scans in hepatic veins occlusion in Budd-Chiari syndrome.

Authors:  Xiao-chun Meng; Kang-Shun Zhu; Jie Qin; Jian-sheng Zhang; Xiao-hong Wang; Yan Zou; Ya-qin Zhang; Hong Shan
Journal:  Chin Med J (Engl)       Date:  2007-01-20       Impact factor: 2.628

7.  Budd-Chiari syndrome: diagnosis with three-dimensional contrast-enhanced magnetic resonance angiography.

Authors:  Jiang Lin; Xiao-Hai Chen; Kang-Rong Zhou; Zu-Wang Chen; Jian-Hua Wang; Zhi-Ping Yan; Ping Wang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 8.  Budd-Chiari syndrome: imaging review.

Authors:  Varun Bansal; Pankaj Gupta; Saroj Sinha; Narender Dhaka; Naveen Kalra; Rajesh Vijayvergiya; Usha Dutta; Rakesh Kochhar
Journal:  Br J Radiol       Date:  2018-07-24       Impact factor: 3.039

9.  Accuracy of computed tomographic angiography in the diagnosis of patients with inferior vena cava partial obstruction in Budd-Chiari syndrome.

Authors:  Shi-Yi Liu; Ping Xiao; Hui-Cun Cao; Hao-Sheng Jiang; Tian-Xiao Li
Journal:  J Gastroenterol Hepatol       Date:  2016-12       Impact factor: 4.029

10.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

View more
  2 in total

1.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

Review 2.  An Update on the Management of Budd-Chiari Syndrome.

Authors:  A Sharma; S N Keshava; A Eapen; E Elias; C E Eapen
Journal:  Dig Dis Sci       Date:  2020-07-20       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.